Hifen

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hifen

What is Hifen? Definition and Primary Classification

Property Description
Active ingredient Cefixime
Form Oral suspension, tablets, capsules
Pharmacological class Antibiotic (Third-Generation Cephalosporin)
General purpose Anti-infective agent (to eradicate susceptible bacteria)
Origin Synthetic (Semi-synthetic)

Hifen is a prescription-only medicine whose active component is Cefixime, fundamentally defining it as an antibiotic. It belongs to the cephalosporin family, specifically classified as a third-generation agent, indicating its advanced chemical structure and targeted activity. This classification is critical because it positions Hifen as a powerful, synthetic tool designed exclusively to counteract and eliminate harmful bacterial infections within the body. Third-generation cephalosporins, unlike older classes such as penicillin, are engineered to be effective against a broad spectrum of microbes and often exhibit increased stability against bacterial resistance enzymes (beta-lactamases). Cefixime is characterized by its reliable and consistent bactericidal effect against susceptible organisms.


Composition, Origin, and Available Forms

The core of Hifen is the single active ingredient, Cefixime, and it is supplied as a synthetic compound in several oral dosage forms to facilitate administration. These forms commonly include standard tablets or capsules, alongside an oral suspension preparation, a distinctive feature often aimed at a pediatric patient group or individuals who have difficulty swallowing. The availability of the oral suspension is an important aspect of its formulation, as it ensures that the effective anti-infective treatment can be flexibly delivered to various patient groups. All forms contain the identical bactericidal agent, Cefixime, suspended in appropriate pharmaceutical vehicles and excipients.


How Does Cefixime Work and What is its General Purpose?

The general purpose of Hifen is to serve as an anti-infective agent to eradicate the underlying source of a bacterial infection. For example, it is typically used in scenarios where a bacterial cause for an illness is confirmed or strongly suspected. This medicine works by targeting and inhibiting bacterial cell wall synthesis. The active molecule, Cefixime, interferes with essential bacterial enzymes, called penicillin-binding proteins, which halts the formation of the bacteria's rigid protective outer layer, ultimately killing the infectious organism and establishing the general benefit of resolving various illnesses caused by susceptible pathogens.

Regulatory References

  1. Cefixime: MedlinePlus Drug Information

What side effects are possible with Hifen?

Possible Side Effects and Safety Information

The official safety profile of Hifen (Cefixime) is documented through regulatory sources, organizing adverse reactions by system-organ class (SOC) and frequency.


Frequency-Classified Adverse Reactions

The majority of expected reactions are Common (ge 1%), primarily involving the Gastrointestinal Disorders SOC. These commonly documented effects include diarrhea (often loose stools), abdominal pain, nausea, and dyspepsia. Less frequent, or Uncommon, reactions include vomiting and transient elevations in liver enzymes (AST, ALT, alkaline phosphatase), as noted in regulatory labeling.


Serious Adverse Reactions and Systemic Constraints

Official prescribing information documents the risk of rare but clinically significant events. These Serious Adverse Reactions include severe hypersensitivity, such as anaphylactic/anaphylactoid reactions and life-threatening Severe Cutaneous Adverse Reactions (SCARs) like Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). Serious gastrointestinal complications include Clostridium difficile-associated diarrhea (CDAD), which may occur during or up to two months after treatment. Neurologic events such as seizures and encephalopathy have also been reported, particularly in specific risk groups.


Population-Specific Safety and Limitations

Safety constraints exist for certain populations. Patients with pre-existing renal impairment require particular caution, as the drug's reduced elimination can increase the risk of CNS effects. Safety and efficacy have not been established in infants less than six months of age. A key limitation is the documented risk of cross-hypersensitivity in individuals with a known allergy to beta-lactam antibacterial agents (e.g., penicillins).

Overdose and Emergency Response

Overdose and When to Seek Help — Hifen (Cefixime) Official Regulatory Information

The following information on overdose is derived from official governmental regulatory documents.

Overdose Manifestations and Potential Serious Outcomes

Overdose Presentation Physiological System Affected
Seizures (Fits) Central Nervous System
Severe Vomiting Gastrointestinal System
Encephalopathy (Brain damage) Central Nervous System

Taking more than the prescribed dose of this medicine may lead to an overdose. The most critical risk is encephalopathy, a condition indicating potential damage to the brain, which may manifest as confusion, altered consciousness, and movement disorders, particularly in cases of overdose or in patients with pre-existing renal impairment. Severe vomiting and seizures are also documented signs of excessive exposure.

Immediate Emergency Action Required

Seek medical care immediately if you suspect you have taken an overdose or if any of the above symptoms are observed, even if they are not yet severe. You must consult a doctor or contact a medical emergency helpline right away if you believe you have taken too much Hifen, as this is a potentially serious medical event requiring prompt professional assessment. Specific treatment for Cefixime overdose is generally supportive and symptomatic, with close patient monitoring being essential.

Therapeutic Uses of Hifen

Hifen (Cefixime) is an antibiotic used to address bacterial infections and is relevant for easing symptoms related to acute bacterial illnesses that interfere with daily functioning.

The medicine is commonly used across conditions presenting with acute episodes affecting the ear, throat, and urinary systems. These primary indications include uncomplicated Acute Otitis Media, tonsillitis and pharyngitis (strep throat), acute exacerbations of chronic bronchitis, and uncomplicated urinary tract infections (UTIs). Hifen is applied across domains where additional symptomatic support is needed, helping patients cope more steadily with the acute phase of illness.

Benefits and Symptom Relief

Hifen is relevant in clinical settings for treating these infections by addressing the bacterial etiology of the condition. This provides support that helps ease the overall symptom burden, particularly pain and fever associated with systemic imbalance and localized inflammatory states. By addressing the bacterial etiology, this use contributes to easing the overall symptom load and supports patients during periods of heightened symptoms. This approach may assist with maintaining functional stability and supports general well-being during symptomatic phases.

Quick Fact: Relief for Acute Discomfort
This medication is commonly used to help ease symptoms related to physical discomfort and systemic imbalance, often associated with conditions involving inflammatory or irritative processes.

Regulatory References

  1. NIH DailyMed drug information

Eligibility and Restrictions for Use

Who Can and Cannot Use Hifen?

The eligibility for using Hifen (Cefixime) is governed by official regulatory criteria, which delineate approved populations and specific health conditions that restrict or prohibit its use. This information is based strictly on government-approved prescribing labels and must be consulted before use.

Populations and Conditions Defining Eligibility

Criteria Official Regulatory Statement
Absolute Contraindication Individuals with a known allergy or severe hypersensitivity to Cefixime, any other cephalosporin antibiotic, or other beta-lactam agents (e.g., penicillin) must not use Hifen.
Approved Age Group The medicine is approved for use in adults and pediatric patients aged six months and older.
Use Not Established Safety and efficacy have not been established in infants less than six months of age, and use is generally not recommended in this group.
Renal Impairment Patients with significantly impaired renal function require special consideration; a mandatory dose adjustment is specified by regulators for adults with creatinine clearance below 60 mL/min.
Pregnancy/Lactation Hifen should be used during pregnancy only if clearly needed (Category B). For nursing mothers, official labeling advises considering temporarily discontinuing breastfeeding during therapy.
Specific Form Restriction The chewable tablet form is restricted for patients with Phenylketonuria (PKU) as it contains phenylalanine.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Regulatory documents detail specific interactions that affect drug exposure, efficacy, and systemic risk. Co-administration with coumarin-type anticoagulants, such as Warfarin, has been associated with increased Prothrombin Time (PT), presenting a documented risk. Similarly, co-administration with potentially nephrotoxic agents (like Aminoglycoside antibiotics) or strong-acting loop diuretics carries a specific, increased risk of impairment of renal function due to additive toxicity.


Drug Level and Efficacy Alterations

The antibiotic’s exposure is formally modified by certain medicines. For example, Nifedipine may increase Cefixime's bioavailability by up to 70%, while Probenecid increases Cefixime serum concentration through reduced renal clearance. Conversely, Cefixime has been reported to lead to elevated plasma levels of Carbamazepine. Furthermore, official prescribing information notes that concurrent use may reduce the efficacy of hormonal oral contraceptives. No mandatory timing rule is documented; Cefixime can be taken with or without food.


Population-Specific Constraints

Patients with markedly impaired renal function require a formal assessment of dosage, which is an interaction-related constraint necessary to manage the risk of drug accumulation due to altered clearance. This constraint ensures that exposure levels do not exceed safe thresholds in this population.

Mechanism of Action

Ontology: How Hifen Works — Mechanism of Action

Targeting the Body’s Oxygen Sensor (PHD Inhibition)

Hifen acts as an inhibitor of Prolyl Hydroxylase Domain (PHD) enzymes , the key cellular oxygen sensors. By blocking PHDs, Hifen prevents the degradation of the HIF-1alpha protein, initiating the core mechanistic cascade that is characteristically activated during cellular low-oxygen conditions.

Activating the Hypoxia Signaling Cascade

The stabilized HIF-1alpha protein accumulates in the cell nucleus, where it activates the transcription of numerous genes via the Hypoxia Response Element (HRE). This fundamental genetic modulation shifts cellular function, resulting in a gene expression profile characteristic of the body's response to low oxygen.

Systemic Modulation of Erythropoiesis

The primary systemic consequence is the strong upregulation of the Erythropoietin (EPO) gene. This leads to a controlled increase in EPO hormone levels, which then stimulates the bone marrow to produce more red blood cells, resulting in an increase in the blood's oxygen-carrying components (hemoglobin and red blood cells).

Dosage and Administration Information

How Hifen (Cefixime) is Used

The principles for using Hifen, which contains the active ingredient Cefixime, are detailed in clinical documentation, outlining the approved routes, standard dosing ranges, and adjustments for specific patient populations.


Official Administration and Dosing

The officially approved route of administration for Cefixime is oral (by mouth). The medication is supplied in multiple oral dosage forms, including tablets, capsules, and oral suspension.

Administration Focus Standard Guideline (Adults 45 kg or > 12 years)
Standard Dose 400 mg daily
Frequency Pattern Once daily (400 mg) OR Divided in two doses (200 mg every 12 hours)
Intake Condition May be taken with or without food

Use Patterns and Duration

For most infections, the typical duration for a course of Cefixime treatment is generally 7 to 14 days. However, for infections caused by Streptococcus pyogenes (e.g., pharyngitis/tonsillitis), the therapeutic dosage is administered for a minimum of 10 days.

For pediatric patients 6 months or older, dosing is weight-based, typically 8 mg per kg of body weight per day. The oral suspension is the form primarily used for this age group.

Dose Adjustments

Dosage modification is required for patients with compromised renal function, as the medication is primarily eliminated by the kidneys. For adults with a Creatinine Clearance (CrCl) of 20 mL/min or less (including those on dialysis), the dose is typically reduced to 200 mg daily. The administration of the oral suspension requires reconstitution with water and must be accurately measured with a calibrated device.

Recent Clinical Evidence

Hifen: Recent Clinical Evidence

Evidence for Use in Acute Otitis Media (AOM)

Research for AOM primarily involved short-term Randomized Controlled Trials (RCTs), where researchers explored how symptoms change over time in pediatric patients (children 6 months and older). The findings from these trials describe patterns observed during the study periods, documenting measured high rates of clinical outcomes related to improvement and the eradication of susceptible bacteria. Some trials reported that the documentation of bacterial eradication against certain strains, such as particular types of S. pneumoniae, was measured as being lower than documented findings for other agents studied.

Evidence for Use in Pharyngitis and Tonsillitis

The evidence for Hifen in throat infections involves comparative studies and short-term clinical trials in both adult and pediatric patients. These studies explored the rates of clinical response and bacteriological eradication of the causative bacteria. Findings indicate that measured bacteriological eradication rates were consistent with those documented for other established treatments over the ten-day regimen. The available research focuses strictly on the resolution of the acute episode.

Evidence for Use in Urinary Tract Infections (UTIs) and Chronic Bronchitis (AECB)

The evidence base for Hifen in uncomplicated UTIs consists of Comparative Clinical Studies and Systematic Reviews. Findings indicate that measured outcomes related to clinical response may vary depending on the duration of the regimen studied. For Acute Exacerbations of Chronic Bronchitis (AECB) in adults, trials monitored high-level outcomes such as measured clinical response rates and bacterial eradication. Research suggests certain shorter-duration regimens were evaluated in some studies with findings similar to those of longer ones, although results were varied.

What is Still Uncertain About the Research

Clinical trials for antibiotics like Hifen are typically designed as short-term studies, meaning there is limited information for long-term outcomes regarding the durability of the initial response or recurrence rates. Data for certain specific patient groups, such as those with highly specific comorbidities or certain levels of chronic organ dysfunction, remain insufficient in the core RCTs. Additionally, the documented research for single-dose applications is heavily influenced by constant monitoring of growing bacterial resistance.

Frequently Asked Questions (FAQ)

Common questions about Hifen (FAQ)


Q: What is the main reason a doctor might prescribe Hifen?

Hifen, which contains Cefixime, is described in official regulatory documents as being used for the treatment of certain bacterial infections. This includes specific infections of the ear (otitis media), throat (pharyngitis/tonsillitis), lower respiratory tract (bronchitis), and uncomplicated urinary tract infections. These uses are based on clinical findings documented in the official prescribing information.


Q: Are headaches a commonly reported side effect of Hifen?

Official adverse event data from regulatory documents reports that headache is a nervous system disorder that may occur with Hifen use. The most commonly reported side effects overall, however, often involve symptoms affecting the digestive system (like diarrhea and nausea).


Q: What kind of side effects are considered common when taking Hifen?

According to official product information, the most commonly reported effects involve the digestive system. These frequently include diarrhea, nausea, loose stools, and abdominal pain. This descriptive information is derived from the systematic monitoring of patient experience during clinical studies.


Q: What are the serious, but less common, side effects mentioned for Hifen?

Regulatory warnings describe the possibility of certain serious effects, including severe allergic reactions (hypersensitivity) and Clostridium difficile-associated diarrhea (CDAD), which is a severe form of diarrhea. Official guidance encourages awareness of potential serious effects mentioned in the drug label.


Q: Is Hifen suitable for use by children?

Official labeling includes specific weight-based dosing recommendations for pediatric patients generally starting from 6 months of age. The oral suspension form is often prescribed for this age group, which is a descriptive overview of the medication’s use based on regulatory approval.


Q: Are there specific age restrictions for using Hifen, according to official information?

Official information provides specific weight-based dosing for children 6 months and older and specific adult dosing for those over 12 years. The prescribing information includes specific considerations for use in the elderly, often related to kidney function, but does not define a maximum age restriction.


Q: Is Hifen safe for people with liver conditions?

Official documents do not specify a mandatory dose adjustment solely for liver impairment, but they note that this class of antibiotics may be associated with coagulation changes in patients with hepatic impairment. Additionally, changes in liver function tests have been reported as adverse events.


Q: Can individuals with kidney problems use Hifen?

Individuals with reduced kidney function may require a formal dosage adjustment to manage the amount of medication in the body, as detailed in the official prescribing information. This is necessary because the kidneys primarily clear the medication from the body, affecting the drug's concentration.


Q: What research is available regarding the long-term use of Hifen?

Clinical trials for this type of antibiotic are typically designed as short-term studies focusing on the resolution of an acute infection. Official research summaries therefore indicate that there is limited information available concerning long-term patient outcomes, recurrence rates, or the durability of the initial response over extended periods.


Q: What should be done if I experience a potential allergic reaction to Hifen?

Official guidance indicates that if an allergic reaction occurs, the use of the drug is generally discontinued right away. Regulatory information describes serious hypersensitivity reactions as a risk, indicating the need to stop the medication if an allergic effect is experienced.


Q: Can women who are pregnant or breastfeeding use Hifen?

Hifen is classified as Pregnancy Category B. Its use during pregnancy is generally reserved for situations when it is clearly needed and the potential benefit is considered to outweigh the potential risk. The drug is known to be excreted into human milk, and official guidance suggests a decision be made to discontinue nursing or discontinue the drug.


Q: How quickly do people generally notice the effects of Hifen?

Official pharmacokinetic data describes how the drug is processed in the body. This information indicates that peak concentrations of the drug in the bloodstream are generally reached between 2 and 6 hours after taking a single oral dose. This peak corresponds to when the drug is most active in the body.


Q: If I forget to take Hifen, what information is usually provided about missing a dose?

Patient counseling instructions state that if a dose is missed, it can be taken as soon as possible, unless it is close to the time for the next scheduled dose. In that case, patient counseling information suggests skipping the missed dose entirely. Official guidance also describes that doses are not intended to be doubled to compensate for a missed one.


Q: Does Hifen have a potential interaction with alcohol consumption?

Regulatory documents detailing drug interactions do not report a major interaction between Hifen and the consumption of alcohol. The official prescribing information does not list alcohol as a specific item that must be avoided.


Q: What is the generally expected duration of the effects of one Hifen dose?

Pharmacokinetic data in the prescribing information describes the drug's elimination half-life, which is the time it takes for half of the drug to be removed from the body. This half-life is typically stated to range from 3 to 4 hours.


Q: Is Hifen classified as a narcotic or controlled substance?

Official US government sources classify Hifen as not being a controlled substance. This means it is not included in the schedules of the Controlled Substances Act, which classifies drugs based on their potential for abuse or dependence.


Q: What kind of monitoring is sometimes recommended while taking Hifen?

Official warnings note that specific monitoring may be necessary for certain populations. For instance, for patients taking blood thinners (anticoagulants) or those with impaired kidney function, the monitoring of blood markers like prothrombin time or kidney function may be recommended.


Q: Are there different brand names or generic versions available for Hifen?

The active ingredient, Cefixime, is available in generic form. In the U.S., a common brand name mentioned in product information is Suprax. Official documents identify the drug by both its active ingredient and its approved trade names.


Q: How should Hifen be stored according to the manufacturer's directions?

The medication should be stored in a closed container at room temperature, protected from heat, moisture, and light. If using the liquid (oral suspension) form, it may require refrigeration, and any unused portion should be discarded after 14 days following reconstitution, as directed by the manufacturer.


Q: Can Hifen affect a person's ability to drive or operate machinery?

Prescribing information indicates that if a person experiences certain side effects that can affect consciousness or movement, such as dizziness or confusion, the ability to drive or operate machinery may be affected. This is a standard precaution linked to potential neurological effects.


Q: Does Hifen need to be stopped gradually, according to official instructions?

Official guidance generally describes completing the entire course of treatment as prescribed to ensure the infection is treated. The prescribing information indicates that the treatment is not typically described as requiring a gradual reduction in dose.


Q: Is there a Black Box Warning associated with Hifen in the U.S. regulatory documents?

The U.S. Food and Drug Administration (FDA) prescribing information for Hifen does not contain a Black Box Warning. This is the strongest safety statement the FDA requires and its absence indicates the drug does not carry this specific, high-level risk communication.


Q: What is the active ingredient in Hifen?

The active ingredient in Hifen is Cefixime. Official product documentation always identifies the medication by its active chemical component, which is Cefixime.


Q: How long does it typically take for Hifen to leave the body after the last dose?

Official pharmacokinetic data describes the drug's elimination, noting its half-life is typically 3 to 4 hours. It also states that approximately 50% of the absorbed dose is generally excreted unchanged in the urine within 24 hours after administration.


Q: Why do official documents state Hifen should be used with caution in elderly patients?

Official information often links the caution in elderly patients to the need for dose adjustment if the patient's kidney function is reduced. This is due to the age-related decline in kidney clearance, which affects how effectively the body removes the medication and is a common consideration for this drug class.


Q: Can Hifen interfere with lab test results?

Official prescribing information indicates that Hifen may cause false positive results with certain non-enzymatic urine tests for sugar (diabetic testing products). It may also affect the results of certain other lab tests, a fact that is included in the drug interaction section.


Q: What patient information resources are officially recommended for Hifen?

Authoritative resources like the NIH MedlinePlus Drug Information pages and the FDA DailyMed label provide comprehensive government-sourced patient-friendly information about Hifen. Consulting these official, verified resources is a reliable way to get descriptive information about the drug.


Q: What types of mental or emotional changes are sometimes reported with Hifen use?

Side effects related to the nervous system that have been reported include headache, dizziness, and, rarely, more serious effects like confusion or encephalopathy (a form of brain dysfunction). These reports are noted in the adverse reactions section, particularly in patients with reduced kidney function.


Q: Can Hifen be crushed or split?

The instructions depend on the specific dosage form. Patient counseling information indicates that capsules should be swallowed whole, but some tablets may be split or cut, and chewable tablets should be crushed or chewed before swallowing.

How should Hifen be stored and disposed of?

Storage and Disposal Instructions

Hifen (Cefixime) must be stored according to its dosage form. Tablets, capsules, and the dry powder for oral suspension must be kept in the original, tightly closed container at room temperature (20^circC to 25^circC), away from excess heat and moisture.

Once reconstituted, the liquid suspension may be stored at room temperature or refrigerated; it must not be frozen and any unused portion must be discarded after 14 days. All forms of the medicine must be stored out of the sight and reach of children.

Disposal should ideally follow a drug take-back program. Otherwise, mix the medicine with an undesirable substance like coffee grounds, seal it in a bag, and discard it in the household trash. Do not dispose of the medication by flushing it down a toilet or sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Hifen found in:

A-Z Index: